Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;14(2):327-337.
doi: 10.1007/s12265-020-10062-z. Epub 2020 Jul 24.

Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance

James Xu  1   2 , Sidney Lo  3   4 , Craig P Juergens  3   4 , Dominic Y Leung  3   4
Affiliations
Review

Impact of Targeted Therapies for Coronary Microvascular Dysfunction as Assessed by the Index of Microcirculatory Resistance

James Xu et al. J Cardiovasc Transl Res. 2021 Apr.

Abstract

Coronary microvascular dysfunction (CMD) has emerged as an important therapeutic target in the contemporary management of ischemic heart disease. However, due to a lack of a reliable traditional "gold standard" test for CMD, optimal treatment remains undefined. The index of microcirculatory resistance (IMR) is an intra-coronary wire-based technique that provides a more reliable and quantitative assessment of CMD and has been increasingly used as a preferred endpoint for evaluating CMD treatment strategies in recent studies. IMR can help diagnose CMD in angina patients with non-obstructive epicardial coronary disease, predict peri-procedural myocardial infarction in stable patients undergoing coronary stenting, and predict long-term prognosis after acute myocardial infarction. Studies of IMR in the setting of non-ST-elevation acute coronary syndromes are still lacking. This review critically appraises the current published literature evaluating targeted therapies for CMD using IMR as the assessment tool and provides insights into evidence gaps in this important field. The index of microcirculatory resistance has rapidly evolved from a research tool to being the new "gold standard" test for evaluating coronary microvascular dysfunction.

Keywords: Coronary microvascular dysfunction; Index of microcirculatory resistance; Percutaneous coronary intervention.

PubMed Disclaimer

References

    1. Britten, M. B., Zeiher, A. M., & Schachinger, V. (2004). Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coronary Artery Disease, 15(5), 259–264. - PubMed
    1. Pepine, C. J., Anderson, R. D., Sharaf, B. L., Reis, S. E., Smith, K. M., Handberg, E. M., et al. (2010). Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia. Journal of the American College of Cardiology, 55(25), 2825–2832. - PubMed - PMC
    1. Sara, J. D., Widmer, R. J., Matsuzawa, Y., Lennon, R. J., Lerman, L. O., & Lerman, A. (2015). Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease. JACC. Cardiovascular Interventions, 8(11), 1445–1453. - PubMed
    1. Marinescu, M. A., Loffler, A. I., Ouellette, M., Smith, L., Kramer, C. M., & Bourque, J. M. (2015). Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC: Cardiovascular Imaging, 8(2), 210–220. - PubMed
    1. Layland, J. J., Whitbourn, R. J., Burns, A. T., Somaratne, J., Leitl, G., Macisaac, A. I., et al. (2012). The index of microvascular resistance identifies patients with periprocedural myocardial infarction in elective percutaneous coronary intervention. Heart., 98(20), 1492–1497. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources